Home sellers in central London are facing a reality check that few of them want to accept – their properties may well be worth less than what they paid for them.Read More

You might also be interested in reading Zevra Therapeutics signals accelerated MIPLYFFA adoption and $148.3M capital infusion while expanding global reach.